Precision therapies from the immune response

Atreca is applying its human immune response profiling technology to generate and develop a novel class of cancer immunotherapeutics that drive and focus the activity of anti-cancer immune responses... Learn more >


A novel class of immuno-oncology therapeutics that direct and enhance checkpoint inhibition

More +

IRC™ TEchnology

Our proprietary immune profiling technology provides unparalleled insight

More +

About Atreca

A dedicated team of molecular biologists, immunologists, drug developers and computational biologists

More +